1
5
| Cat. No. | Product Name | ||
|---|---|---|---|
| L1600 | 激酶抑制剂库 | 2230 compounds | |
| 2230种激酶抑制剂的独特集合，用于特定靶向激酶，可用于高通量筛选和高内涵筛选； | |||
| L2200 | 酪氨酸激酶分子库 | 746 compounds | |
| 746种酪氨酸激酶抑制剂的独特集合，可用于高通量筛选和高内涵筛选； | |||
| L1610 | FDA 上市激酶抑制剂库 | 280 compounds | |
| TargetMol FDA上市激酶库包含280个具有明确激酶抑制活性的上市药物 | |||
| L3510 | 甲基化化合物库 | 131 compounds | |
| 131种甲基化相关的化合物，可以用于高通量和高内涵筛选； | |||
| L1720 | 核苷类化合物库 | 337 compounds | |
| 337种核苷类化合物，包括核苷酸、核苷酸类似物及衍生物等，适用于抗病毒、抗肿瘤、抗真菌、抗抑郁等药物的研发； | |||
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T4497L |
Amifampridine phosphate
BRN-0110232; 3,6-DAP; BRN0110232; BRN 0110232; SC10; NSC 521760 |
||
| Amifampridine is mainly used to treat many rare muscle diseases. In the United States, aminopyridine is being studied for the treatment of Lambert-Eaton myasmus syndrome (LEMS). Amifampridine is also used to treat many congenital myasthenia syndromes, par | |||
沪公网安备 31010602006700号
